Clinical Trials Browser

NIH × Melanoma × Imatinib Mesylate × Clear all

NCT00074308 2018-06-20

Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers

Phase 1/2 Completed

40 enrolled 10 charts

Melanoma

NCT00470470 2014-12-23

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Phase 2 Completed

30 enrolled 7 charts

Melanoma